REFERENCES

1. EJP RD. Project structure. The European joint programme on rare diseases: presentation. Available from: https://www.ejprarediseases.org/what-is-ejprd/project-structure/ [Last accessed on 17 Jun 2024].

2. IRDiRC. Who we are. Introduction to the international rare diseases research consortium (IRDiRC). Available from: https://irdirc.org/who-we-are-2/ [Last accessed on 17 Jun 2024].

3. IRDiRC. Visions and goals. Available from: https://irdirc.org/about-us/vision-goals/ [Last accessed on 17 Jun 2024].

4. EJP RD. What is EJP RD? Governance. Available from: https://www.ejprarediseases.org/what-is-ejprd/governance/ [Last accessed on 17 Jun 2024].

5. IRDiRC. Scientific committees. Available from: https://irdirc.org/scientific-committees/ [Last accessed on 17 Jun 2024].

6. RE(ACT) congress and IRDiRC conference 5-7 March 2025 Brussels. Available from: https://www.react-congress.org/ [Last accessed on 17 Jun 2024].

7. EJP RD. Innovation management toolbox. Available from: https://imt.ejprarediseases.org/ [Last accessed on 17 Jun 2024].

8. Hechtelt Jonker A, Hivert V, Gabaldo M, et al. Boosting delivery of rare disease therapies: the IRDiRC orphan drug development guidebook. Nat Rev Drug Discov 2020;19:495-6.

9. EURORDIS. Who we are. Available from: https://www.eurordis.org/who-we-are/our-vision-mission/ [Last accessed on 17 Jun 2024].

10. EURORDIS. Who we are - projects and partnerships - EJP on RD. Available from: https://www.eurordis.org/projects/ejp-on-rd/ [Last accessed on 17 Jun 2024].

11. The National Mirror Groups (NMGs). European joint programme on rare diseases. Available from:: https://www.youtube.com/watch?v=BbGjlsG0-RE [Last accessed on 17 Jun 2024].

12. EJP RD. Funded projects. Available from: https://www.ejprarediseases.org/our-actions-and-services/funding-opportunities/funded-projects/. [Last accessed on 17 Jun 2024].

13. EJP RD. Short guide on patient partnerships in rare diseases research projects. Available from: https://www.ejprarediseases.org/wp-content/uploads/2021/03/SHORT-GUIDE-ON-PATIENT-PARTNERSHIPS-IN-RARE-DISEASE-RESEARCH-PROJECTS.pdf [Last accessed on 17 Jun 2024].

14. EJP RD. Patients’ training. https://www.ejprarediseases.org/our-actions-and-services/training-and-education/patients-training/ [Last accessed on 17 Jun 2024].

15. EJP RD. Networking support scheme (NSS) call. Available from: https://www.ejprarediseases.org/our-actions-and-services/funding-opportunities/calls/networking-support/ [Last accessed on 17 Jun 2024].

16. EJP RD. Rare diseases research (RDR) challenges call. Available from: https://www.ejprarediseases.org/rare-diseases-challenges/ [Last accessed on 17 Jun 2024].

17. EJP RD. Funded projects: internal call for proposals 2019 - clinical trials methodology demonstration projects. Available from: https://www.ejprarediseases.org/funded-projects-demonstration/ [Last accessed on 17 Jun 2024].

18. EJP RD. Funded projects: internal call for innovation project in clinical trials methodology. Available from: https://www.ejprarediseases.org/funded-projects-internal-call-for-innovation-project-in-clinical-trials-methodology/ [Last accessed on 17 Jun 2024].

19. Orphanet database. Knowledge on rare diseases and orphan drugs. Available from: www.orpha.net [Last accessed on 17 Jun 2024].

20. The EJP RD virtual platform. Available from: https://vp.ejprarediseases.org/ [Last accessed on 17 Jun 2024].

21. EJPRD. Virtual platform specification (VIPS) V2.0. Available from: https://www.ejprarediseases.org/wp-content/uploads/2023/05/EJPRD_P2_AD49_PU_Virtual-Platform-Specification-V2.0.pdf [Last accessed on 17 Jun 2024].

22. EJP RD. FAIRification. Available from: https://www.ejprarediseases.org/fairification/ [Last accessed on 17 Jun 2024].

23. EJP RD. D11.11 additional facilities integrated to resources regarding data deposition and access, including user guidelines and documentation for data deposition and access. Available from: https://www.ejprarediseases.org/wp-content/uploads/2021/03/EJPRD_P2_D11.11_PU_First-ver_Addition-Facilities-Integrated-Resources_Data-Deposit-Access_FV.pdf [Last accessed on 17 Jun 2024].

24. EJP RD. D11.12 second version additional facilities integrated to resources regarding data deposition and access, including user guidelines and documentation. Available from: https://www.ejprarediseases.org/wp-content/uploads/2021/03/EJPRD_P2_D11.12_PU_2nd-ver_Addition-Facilities-Integrated-Resources_Data-Deposit-Access_VF.pdf [Last accessed on 17 Jun 2024].

25. EJP RD. D11.13 third version additional facilities integrated to resources regarding data deposition and access, including user guidelines and documentation. Available from: https://www.ejprarediseases.org/wp-content/uploads/2022/01/EJPRD_P2_D11.13_PU_3rd-ver_Addition-Facilities-Integrated-Resources_Data-Deposit-Access_VF.pdf [Last accessed on 17 Jun 2024].

26. EJP RD. D11.14 fourth version additional facilities integrated to resources regarding data deposition and access, including user guidelines and documentation. Available from: https://www.ejprarediseases.org/wp-content/uploads/2023/02/EJPRD_P2_D11.14_PU_4th-ver_Additional-Facilities-Integrated-Resources_Data-Deposit-Access_VF.pdf [Last accessed on 17 Jun 2024].

27. EJP RD. D11.15 fifth version additional facilities integrated to resources regarding data deposition and access, including user guidelines and documentation. Available from: https://www.ejprarediseases.org/wp-content/uploads/2024/02/EJPRD_P2_D11.15_PU_5th-ver_Additional-Facilities-Integrated-Resources_Data-Deposit-Access_VF.pdf [Last accessed on 17 Jun 2024].

28. EJP RD. D11.16 first report on processed genome-phenome datasets and multi-omics use cases analysed, including description of new cloud and online analysis functionalities and tools. Available from: https://www.ejprarediseases.org/wp-content/uploads/2021/03/EJPRD_P2_D11.16_PU_1st-Report-Processed-Genome-Phenome-Datasets-and-Multi-Omics-Use-Cases-Analysed_VF.pdf [Last accessed on 17 Jun 2024].

29. EJP RD. D11.17 second report on processed genome-phenome datasets and multi-omics use cases analysed, including description of new cloud and online analysis functionalities and tools. Available from: https://www.ejprarediseases.org/wp-content/uploads/2021/03/EJPRD_P2_D11.17_PU_2nd-Report-Processed-Genome-Phenome-Datasets-Multi-Omics-Use-Cases-Analysed_VF.pdf [Last accessed on 17 Jun 2024].

30. EJP RD. D11.18 third report on processed genome- phenome datasets and multi-omics use cases analysed, including description of new cloud and online analysis functionalities and tools. Available from: https://www.ejprarediseases.org/wp-content/uploads/2022/01/EJPRD_P2_D11.18_PU_3rd-Report-Processed-Genome-Phenome-Datasets-Multi-Omics-Use-Cases-Analysed_VF.pdf [Last accessed on 17 Jun 2024].

31. EJP RD. D11.19 fourth report on processed genome-phenome datasets and multi-omics use cases analysed, including description of new cloud and online analysis functionalities and tools. Available from: https://www.ejprarediseases.org/wp-content/uploads/2023/02/EJPRD_P2_D11.19_PU_4th-Report-Processed-Genome-Phenome-Datasets-Multi-Omics-Use-Cases-Analysed_VF.pdf [Last accessed on 17 Jun 2024].

32. EJP RD. D13.01 collection of (at least) 20 curated pathways in a (sub)portal on WikiPathways. Available from: https://www.ejprarediseases.org/wp-content/uploads/2022/01/EJPRD_P2_D13.01_PU_Collection-of-curated-pathways-sub-Portal-WikiPathways_VF.pdf. [Last accessed on 17 Jun 2024].

33. EJP RD. D13.2 completed pathway analysis workflow (data analysis including both types of genetic variant linking and network creation). Available from: https://www.ejprarediseases.org/wp-content/uploads/2023/02/EJPRD_P2_D13.02-AD50-AD51_PU_Completed-pathway-analysis-workflow.pdf [Last accessed on 17 Jun 2024].

34. EJP RD. Deliverable 13.3 completed network analysis workflow (active node detection, lifestyle factor network evaluation and extended network analysis for drugs and toxic compounds). Available from: https://www.ejprarediseases.org/wp-content/uploads/2024/02/EJPRD_P2_D13.03_PU_Completed-pathway-analysis-workflow-active-node-detection-lifestyle-factor-network-evaluation-extended-network-analysis-for-drugs-toxic-compounds_VF.pdf [Last accessed on 17 Jun 2024].

35. ELIXIR service bundles for rare diseases. Systems biology service bundles for rare diseases. Available from: https://elixir-europe.org/services/service-bundles/rare-diseases [Last accessed on 17 Jun 2024].

36. EJP RD. General information on training. Available from: https://www.ejprarediseases.org/general-information-training/ [Last accessed on 17 Jun 2024].

37. EJP RD. Mentoring for translational research. Available from: https://www.ejprarediseases.org/mentoring/ [Last accessed on 17 Jun 2024].

38. EJP RD. AD40 report on training gaps identified and solutions proposed. Available from: https://www.ejprarediseases.org/wp-content/uploads/2024/02/EJPRD_P3_AD40_PU_Report-on-Training-Gaps-identified-and-solutions-proposed.pdf [Last accessed on 17 Jun 2024].

39. EJP RD. Research mobility fellowships. Available from: https://www.ejprarediseases.org/our-actions-and-services/funding-opportunities/funded-projects/fellows/ [Last accessed on 17 Jun 2024].

40. EJPRD. ERN workshops. https://www.ejprarediseases.org/our-actions-and-services/training-and-education/ern-workshops/ [Last accessed on 17 Jun 2024].

41. EJP RD MOOC. Diagnosing rare diseases: from the clinic to research and back. Available from: https://www.futurelearn.com/courses/rare-genetic-disease [Last accessed on 17 Jun 2024].

42. EJP RD. D14.2 orphanet nomenclature and ontologies national trainings. Available from: https://www.ejprarediseases.org/wp-content/uploads/2024/02/EJPR-RD_P3_D14.02_PU_Second-Report-of-Orphanet-nomenclature-training-for-trainers-and-national-trainings.pdf [Last accessed on 17 Jun 2024].

43. European joint programme on rare disease (EJP RD). Available from: https://www.ga4gh.org/driver_project/european-joint-programme-on-rare-disease/. [Last accessed on 17 Jun 2024].

44. 1+MG Framework. Rare diseases. Available from: https://framework.onemilliongenomes.eu/rare-diseases [Last accessed on 17 Jun 2024].

45. C-path and the European joint programme on rare diseases to expand global impact and partnership. Available from: https://c-path.org/c-path-and-the-european-joint-programme-on-rare-diseases-to-expand-global-impact-and-partnership [Last accessed on 17 Jun 2024].

46. Alarcon P, Braun I, Hartley E, et al. Leveraging biolink as a “rosetta stone” between C-path and EJP-RD semantic models provides emergent interoperability. J Soc Clin Date Manage 2023;2:1-8.

47. EJP RD. Clinical trials methodology. Available from: https://www.ejprarediseases.org/clinical-trials-methodology/ [Last accessed on 17 Jun 2024].

48. Rare disease moonshot. Available from: https://www.rarediseasemoonshot.eu/ [Last accessed on 17 Jun 2024].

49. EJP RD. European rare diseases research alliance. ERDERA. Available from: https://www.ejprarediseases.org/erdera/ [Last accessed on 17 Jun 2024].

50. European rare diseases partnership strategic research & innovation agenda. Available from: https://www.ejprarediseases.org/wp-content/uploads/2023/05/RDP_SRIA_v1.0_Public_Consultation.pdf [Last accessed on 17 Jun 2024].